Literature DB >> 8131781

The protective effect of serum lipoproteins against bacterial lipopolysaccharide.

T E Read1, H W Harris, C Grunfeld, K R Feingold, J P Kane, J H Rapp.   

Abstract

Lipoproteins bind and inactivate bacterial endotoxin, both in vitro and in vivo. Both cholesterol ester-rich and TG-rich lipoproteins, and TG-rich lipid emulsions can prevent death in mice when pre-incubated with a lethal dose of endotoxin before intraperitoneal administration. Chylomicrons can also prevent death when given intravenously after endotoxin in rats. The metabolic fate of lipoprotein-bound endotoxin appears to be directed by the lipoprotein particle. When administered with chylomicrons, the plasma clearance and hepatic uptake of endotoxin are enhanced. Endotoxin is shunted preferentially to hepatocytes and away from hepatic macrophages, thereby increasing endotoxin excretion [corrected] in bile. The survival benefit and alterations in metabolism afforded by chylomicrons correlate with a reduction in peak serum levels of tumour necrosis factor (TNF), providing a possible mechanism by which lipoproteins protect against endotoxin-induced death. These findings suggest a possible role for lipoproteins or lipid emulsions in the body's defence against endotoxaemia.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8131781

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  19 in total

1.  Regulation of endotoxin-induced proinflammatory activation in human coronary artery cells: expression of functional membrane-bound CD14 by human coronary artery smooth muscle cells.

Authors:  Lynn L Stoll; Gerene M Denning; Wei-Gen Li; James B Rice; Allan L Harrelson; Sara A Romig; Skuli T Gunnlaugsson; Francis J Miller; Neal L Weintraub
Journal:  J Immunol       Date:  2004-07-15       Impact factor: 5.422

2.  Biomarker candidates for the detection of an infectious etiology of febrile neutropenia.

Authors:  Martin E Richter; Sophie Neugebauer; Falco Engelmann; Stefan Hagel; Katrin Ludewig; Paul La Rosée; Herbert G Sayer; Andreas Hochhaus; Marie von Lilienfeld-Toal; Tom Bretschneider; Christine Pausch; Christoph Engel; Frank M Brunkhorst; Michael Kiehntopf
Journal:  Infection       Date:  2015-08-15       Impact factor: 3.553

Review 3.  Abnormalities of Lipoprotein Levels in Liver Cirrhosis: Clinical Relevance.

Authors:  Graziella Privitera; Luisa Spadaro; Simona Marchisello; Giuseppe Fede; Francesco Purrello
Journal:  Dig Dis Sci       Date:  2017-11-25       Impact factor: 3.199

4.  Escherichia coli sepsis increases hepatic apolipoprotein B secretion by inhibiting degradation.

Authors:  H W Phetteplace; N Sedkova; K I Hirano; N O Davidson; S P Lanza-Jacoby
Journal:  Lipids       Date:  2000-10       Impact factor: 1.880

5.  Antiinflammatory effects of reconstituted high-density lipoprotein during human endotoxemia.

Authors:  D Pajkrt; J E Doran; F Koster; P G Lerch; B Arnet; T van der Poll; J W ten Cate; S J van Deventer
Journal:  J Exp Med       Date:  1996-11-01       Impact factor: 14.307

6.  Associations of lipoproteins with cardiovascular and infection-related outcomes in patients receiving hemodialysis.

Authors:  George A Kaysen; Barbara Grimes; Lorien S Dalrymple; Glenn M Chertow; Julie H Ishida; Cynthia Delgado; Mark Segal; Janet Chiang; Tjien Dwyer; Kirsten L Johansen
Journal:  J Clin Lipidol       Date:  2017-12-27       Impact factor: 4.766

7.  The role of tumour necrosis factor in the kinetics of lipopolysaccharide-mediated neutrophil priming in whole blood.

Authors:  H J van Leeuwen; M Van Der Tol; J A G Van Strijp; J Verhoef; K P M van Kessel
Journal:  Clin Exp Immunol       Date:  2005-04       Impact factor: 4.330

8.  LPS-binding protein circulates in association with apoB-containing lipoproteins and enhances endotoxin-LDL/VLDL interaction.

Authors:  A C Vreugdenhil; A M Snoek; C van 't Veer; J W Greve; W A Buurman
Journal:  J Clin Invest       Date:  2001-01       Impact factor: 14.808

Review 9.  Anti-inflammatory properties of lipid oxidation products.

Authors:  Valery N Bochkov; Norbert Leitinger
Journal:  J Mol Med (Berl)       Date:  2003-09-06       Impact factor: 4.599

10.  Lipopolysaccharide-induced production of tumour necrosis factor and interleukin-1 is differentially regulated at the receptor level: the role of CD14-dependent and CD14-independent pathways.

Authors:  M G Netea; B J Kullberg; J W van der Meer
Journal:  Immunology       Date:  1998-07       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.